Skip to main content

Table 2 Cutaneous and mucosal HPV and HHV8 infection as well as TERT mutation frequency stratified by conjunctival neoplasia grades and HIV status

From: Telomerase promoter mutations in human immunodeficiency virus-related conjunctiva neoplasia

  CIN3 + SCC (HIV+) CIN3 + SCC (HIV−) CIN1 + CIN2 (HIV+) CIN1 + CIN2 (HIV−) Control conjunctiva (HIV+) Control conjunctiva (HIV−)
N = 26 (%) N = 15 (%) N = 22 (%) N = 9 (%) N = 28 (%) N = 25 (%)
HPV-Pos 4 (15.4) 0 (0.0) 7 (31.8) 2 (22.2) 0 (0.0) 1 (4.0)
HPV-Neg 22 (84.6) 15 (100.0) 15 (68.2) 7 (77.8) 28 (100.0) 24 (96.0)
HHV8-Pos 3 (11.5) 5 (33.3) 5 (22.7) 2 (22.2) 0 (0.0) 1 (4.0)
HHV8-Neg 23 (88.5) 10 (66.7) 17 (77.3) 7 (77.8) 28 (100.0) 24 (96.0)
TERT-Muta 12 (46.2) 2 (13.3) 7 (31.8) 2 (22.2) 1 (3.6) 0 (0.0)
TERT-Wt 14 (56.8) 13 (86.7) 15 (68.2) 7 (77.8) 27 (96.4) 25 (100.0)
  1. aCIN3 + SCC HIV-positive versus HIV-negative, P value 0.04